GFH647   Click here for help

GtoPdb Ligand ID: 14674

Synonyms: compound Z161 [US20240360154] | GFH-647
Compound class: Synthetic organic
Comment: GFH647 is a non-covalent (reversible) Bruton's tyrosine kinase (BTK) inhibitor. It is one of the compounds claimed in patent US20240360154A1 [1]. GFH647 is intended to treat B cell cancers by targeting wild-type BTK and the ibrutinib resistance mutation BTKC481S.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 8
Hydrogen bond donors 3
Rotatable bonds 6
Topological polar surface area 101.05
Molecular weight 476.91
XLogP 2.3
No. Lipinski's rules broken 0

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

SMILES / InChI / InChIKey
Click here for help
Canonical SMILES C([2H])([2H])([2H])[C@]1(COC([2H])([2H])[2H])C(=O)NC2=C(C3=C(NC=C3C(=O)C4=CC=C(C=C4Cl)OC5=CC=CC=C5)N=C2)N1
Isomeric SMILES N1C=2C=3C(C(C=4C(Cl)=CC(OC=5C=CC=CC5)=CC4)=O)=CNC3N=CC2NC(=O)[C@]1(C([2H])([2H])[2H])COC([2H])([2H])[2H]
InChI InChI=1S/C25H21ClN4O4/c1-25(13-33-2)24(32)29-19-12-28-23-20(21(19)30-25)17(11-27-23)22(31)16-9-8-15(10-18(16)26)34-14-6-4-3-5-7-14/h3-12,30H,13H2,1-2H3,(H,27,28)(H,29,32)/t25-/m0/s1/i1D3,2D3
InChI Key RIADFIQSVUZRGG-FEMLVCHJSA-N

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

References
1. Zhou F, Jiang T, Liu Y, Lin C, Zhang L, Liu Z, Ma K, Xu X, Feng L, Lan X et al.. (2024)
Aroyl substituted tricyclic compound, preparation method therefor and use thereof.
Patent number: US20240360154A1. Assignee: Genfleet Therapeutics Shanghai Inc, Zhejiang Genfleet Therapeutics Co Ltd. Priority date: 21/09/2021. Publication date: 31/10/2024.